GRoningen Early-PD Ambroxol Treatment

Clinical trial NCT05830396 · UNKNOWN

Trial details

NCT number: NCT05830396
Sponsor: University Medical Center Groningen
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Parkinson Parkinson Disease

Start date: 2023-05-01
Primary completion: 2025-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.